
-
Israel strikes Hezbollah operative in Beirut, kills 3
-
Desperate Rohingya mark Eid in Indonesia limbo
-
Sam Kerr has 'full support' of Australia squad, vice-captain says
-
Asian markets edge back but Trump tariff fears dampen mood
-
Teenage opener Konstas gets Australia contract with Ashes on horizon
-
S. Korea court to rule Friday on President Yoon impeachment
-
Myanmar to hold minute of silence for more than 2,000 quake dead
-
Far-right leaders rally around France's Le Pen after poll ban
-
SpaceX launches private astronauts on first crewed polar orbit
-
China launches military drills around Taiwan
-
Political support leading to increasing fallout for crypto
-
France's Le Pen seeks to keep presidency hopes alive after election ban
-
Trump tariffs threaten Latin American steel industry
-
'Tariff man': Trump's long history with trade wars
-
Tariffs: Economic 'liberation' or straitjacket?
-
Undocumented migrants turn to Whatsapp to stay ahead of US raids
-
What next for Venezuela as Trump goes after oil revenues?
-
New Zealand Rugby and Ineos settle sponsorship dispute
-
China says launches military exercises around Taiwan
-
Team New Zealand fails in bid to host 2027 America's Cup
-
Trump says will be 'kind' with tariffs as deadline looms
-
OpenAI says it raised $40 bn at valuation of $300 bn
-
Safely back on Earth, once-stranded US astronauts ready to fly again
-
Syria president says new authorities can't satisfy everyone
-
US robbers who touted crime on Instagram jailed
-
Fernandes 'not going anywhere', says Man Utd boss Amorim
-
US regulators tell 23andMe to protect genetic data
-
Banana man Ashwani Kumar powers Mumbai to first IPL win of season
-
World economies brace for Trump tariffs deadline
-
Syrians rejoice during first Eid after Assad's fall
-
Falling inflation drives down poverty in Argentina: statistics agency
-
Iran will have 'no choice' but to acquire nukes if attacked: Khamenei adviser
-
France's Le Pen defiant after five year election ban
-
Haaland sidelined by injury in major Man City blow
-
Israel's Netanyahu slams Qatargate probe as 'political witch hunt'
-
No technical obstacles to new giant particle collider in Europe: CERN
-
Swing king Ashwani Kumar powers Mumbai to first IPL win of season
-
'Noble work' of Buddhist cremations after Myanmar quake
-
Myanmar to mark minute of silence as quake toll passes 2,000
-
Young Turkish protesters face rude awakening in police custody
-
Pentagon chief orders gender-neutral fitness standards for combat troops
-
Michelin Guide unveils new stars for 68 restaurants in France
-
Trump confident in finding TikTok buyer before deadline
-
Wrexham reap financial rewards of Hollywood tie-up
-
Hamas issues call to arms against displacement as Israel orders new evacuations
-
Gazans flee southern city of Rafah after Israel military orders evacuation
-
Canada candidates promise less reliance on US a month before vote
-
Brathwaite quits as West Indies Test skipper, Hope takes white-ball charge
-
'No excuses' for tired Forest against Man Utd, says Nuno
-
Spain coal mine blast kills five

Genflow Biosciences PLC Announces Holding in Company
LONDON, UNITED KINGDOM / ACCESS Newswire / March 28, 2025 / 1. Issuer Details
ISIN
GB00BP2C3V08
Issuer Name
GENFLOW BIOSCIENCES PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
MR ERIC LEIRE
City of registered office (if applicable)
15 Ingestre Place,
Country of registered office (if applicable)
UK
Name | City of registered office | Country of registered office |
Eric Leire |
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
27-Mar-2025
6. Date on which Issuer notified
27-Mar-2025
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
Resulting situation on the date on which threshold was crossed or reached | 36.180000 | 0.000000 | 36.180000 | 126514999 |
Position of previous notification (if applicable) | 35.600000 | 0.000000 | 35.600000 |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
GB00BP2C3V08 | 126514999 | 36.180000 | ||
Sub Total 8.A | 126514999 | 36.180000% |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
Sub Total 8.B1 |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
Sub Total 8.B2 |
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
27-Mar-2025
13. Place Of Completion
London
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com .
SOURCE: Genflow Biosciences PLC
View the original press release on ACCESS Newswire
Y.Baker--AT